Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women

BACKGROUND: Serum markers are used prior to pelvic imaging to improve specificity and positive predictive value (PPV) of ovarian cancer multimodal screening strategies. METHODS: We conducted a randomized controlled pilot trial to estimate surgical PPV of a “2 of 3 tests positive” screening rule, and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Karlan, Beth Y., Thorpe, Jason, Watabayashi, Kate, Drescher, Charles W., Palomares, Melanie, Daly, Mary B., Paley, Pam, Hillard, Paula, Andersen, M Robyn, Anderson, Garnet, Drapkin, Ronny, Urban, Nicole
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4082470/
https://ncbi.nlm.nih.gov/pubmed/24789859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-13-1361
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller